Leerink Partnrs Weighs in on ACHC Q2 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Acadia Healthcare in a report issued on Wednesday, May 14th. Leerink Partnrs analyst W. Mayo anticipates that the company will earn $0.61 per share for the quarter. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.79 EPS, Q1 2026 earnings at $0.49 EPS, Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.87 EPS, FY2026 earnings at $2.91 EPS and FY2027 earnings at $3.32 EPS.

Other research analysts have also issued research reports about the stock. Mizuho reduced their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 14th. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Guggenheim initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 target price on the stock. Barclays reduced their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Wednesday, May 14th. Finally, Bank of America reduced their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $47.94.

Acadia Healthcare Stock Up 0.5%

Shares of NASDAQ:ACHC opened at $25.20 on Monday. Acadia Healthcare has a 12 month low of $20.36 and a 12 month high of $82.41. The company’s 50-day moving average price is $26.06 and its two-hundred day moving average price is $35.30. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.32 billion, a P/E ratio of 8.26, a P/E/G ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the prior year, the firm earned $0.84 EPS. The company’s revenue was up .3% on a year-over-year basis.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after buying an additional 76,490 shares during the period. FMR LLC grew its stake in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after buying an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock valued at $126,189,000 after buying an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. Finally, Hawk Ridge Capital Management LP boosted its position in Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock worth $74,988,000 after purchasing an additional 2,013,126 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.